Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Improving Glioblastoma Cl" (30 stories)

Top Headline Story

Modern brachytherapy in glioblastoma: overcoming clinical barriers to improve local control
Lead StoryFrontiersgeneral
Jul 1

Modern brachytherapy in glioblastoma: overcoming clinical barriers to improve local control

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOT1lnQVNfaFZySGRSVnNZRUVMZDh2MFdBdGxFVTFyd2lVeE0tbEk1VEFfcC1zbC10aUZTNk8tSkNjclF3eGRUN1I1am9PODF2cUV6YUZkTnJTZmJ0bjM0eHl4UW9QeTJzNWJ0eXVWSVl2aXdvSWptRDdFXzNUM3FDdzlWWlVxY1pQMTA0RmRB?oc=5" target="_blank">Modern brachytherapy in glioblastoma: overcoming clinical barriers to improve local control</a>  <font color="#6f6f6f">Frontiers</font>

Real-time search volume
500+24m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

1000+24m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

200+24m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

200+24m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Search Results for "Improving Glioblastoma Cl"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival in preclinical glioblastoma models
Mayo Clinic News Networktech

Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival in preclinical glioblastoma models

<a href="https://news.google.com/rss/articles/CBMijwJBVV95cUxQdVpUbUFsdXNSQ25pYWdkOTJGNFJNeWJvd3ZnU2dZX1BEY1pvQ2FiRDlaOUtjV0hKZ0ZWSFM2RjhNM3FYLUw3alVjU183WUNzenBXUFBab2FlbmFvaW1taTJrZjhRSG9JZW1QQTJEdTRFVE9ZV2Nia1drYVhjbmhfWXlwblhsUjQ5Q1AyeDlMaVNjcDk2NTBHV0hSeW9xRnBMTjR1TzdLajFmLWxtOXNiSlR6TWxObE5uVjcyeGlZeHFhdVpYY294VnRYUURuYy1MNk5KcFMzc0hJY21rd0RPZUl2ZWlsRURTa1NnZEgyQjU2VzlqUExTZTExTUoyUHZVUUVXcDBFRlVfLVB3WGFn?oc=5" target="_blank">Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival in preclinical glioblastoma models</a>  <font color="#6f6f6f">Mayo Clinic News Network</font>

FA-DeepMSM: a few-shot adapted interpretable multimodal survival model for improved prognostic prediction in glioblastoma
Naturegeneral

FA-DeepMSM: a few-shot adapted interpretable multimodal survival model for improved prognostic prediction in glioblastoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE12cWFUb2YyVWNvVll6UVp6SzV0NzlET1dwcmY5WVNGVU0tS0FJenRNamw2VllxRXEtTlZISTZXalF0OGpsV2JiUk5oTE5TMHUyU0dnbHI5SGhWVXRRTnRr?oc=5" target="_blank">FA-DeepMSM: a few-shot adapted interpretable multimodal survival model for improved prognostic prediction in glioblastoma</a>  <font color="#6f6f6f">Nature</font>

Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain
Wiley & Sonstech

Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBjRmNRYzh1eXR0X2pPcWk4VVo1LUk0Wjc4cXkydkNzSFdaa1U0MEFfU1gzV0o1QlZIaGtxdlpmcW9lSG9rXy1Wb0xWc2h6cHd4bmY2Vk9RdE85dzR6QXFtUUlFUzZld1pDZHh2dmlPNnBEd29jLXc?oc=5" target="_blank">Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain</a>  <font color="#6f6f6f">Wiley & Sons</font>

Integrating biocomputational techniques for vaccine development for glioblastoma multiforme: a possible way of enhancing precision
Frontierstech

Integrating biocomputational techniques for vaccine development for glioblastoma multiforme: a possible way of enhancing precision

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPbDNWa28wd19wYV9fSUY4SF9TRlpWS1owcDlUeXA1RTRRQzFzdmRxcFlNQWVQU0M4Q29hamF0aHo0WGtPei1rRVBwUW9Jb2tvSWdBUTJCZ0tBRzFobHE5YWcyZmxaZFdGR1hvdVRNUW0wNGZ4SlNuWEFxTVZtc2tpaVZsVkJBZkNDUFU0amlnZm1GZw?oc=5" target="_blank">Integrating biocomputational techniques for vaccine development for glioblastoma multiforme: a possible way of enhancing precision</a>  <font color="#6f6f6f">Frontiers</font>

Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming
Science | AAASworld

Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5DYllUTVNrUHVqZXJWVXc1RmliaUx1M3U5cG9vejFrZ1dNSkRTZFItM3dlNm5yUG5UZTNwcVg0NnZpcUY1OG82eHJvc2k2ZHl0eGhNaURxeTltcTRIamJDelVLRkRKMEU?oc=5" target="_blank">Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming</a>  <font color="#6f6f6f">Science | AAAS</font>

Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology
Natureworld

Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBPMDY0TE9oUGo2LWpvckR1M2pTdGJ2UHB1dGhnNUNUNXYzYW5nWDhpTVd3bGxRLWZDY1NhaGx6TGtRUnFRWWxlMlFYeC1zTWc0c3hVZzB2RlRTc3Nzendz?oc=5" target="_blank">Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology</a>  <font color="#6f6f6f">Nature</font>

Glioblastoma in older adults: Improving survival and quality of life
Mayo Clinic News Networkgeneral

Glioblastoma in older adults: Improving survival and quality of life

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPODUtTVhjelo2Q0hLY3h2VE5QaUQ1VFVOVGtGenJCSUxHUXBoNUlTSUprZGFGYjdlYkNNMmpMNHRYQWE2YThWN2Z0cmpNTXdYOTV0aHIzWVhTT0U2ZU55TDRLaHFwQVc5Mnp4eEt0Ymg2SFZXUkhwN1ZOd3VRMTBsenhaVWRLQzlDeExieGMzQWw1V2VsTndFZDRqdnl3VlN2RTlzRHJmMTNyZ2FoeHdWMzZYWVU?oc=5" target="_blank">Glioblastoma in older adults: Improving survival and quality of life</a>  <font color="#6f6f6f">Mayo Clinic News Network</font>

Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression
Naturegeneral

Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE50N3RyZ1BHLTkxTUMwajdKekY3RGhZSXlOd3pYMjV6cEVxNmEteGRLWk1fYlZFWFktb0RaVmpNU1R6Wkd5SDB1WDlsZ05mR0duTUQ1Z3hUSWl4VjZFYVRZ?oc=5" target="_blank">Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression</a>  <font color="#6f6f6f">Nature</font>

An update on the clinical trial research of immunotherapy for glioblastoma
Frontiersworld

An update on the clinical trial research of immunotherapy for glioblastoma

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPREtvTGQtRjAyN2lrYWJYSjBLVk5jbm9GcWw0N1BHY01Nbm9pbFdjYnJ6ZzVsUE1KXy1DVHFmNC1vVG1SMjAwMERKcGUzYUxhQkQzNmwtT0RoMldwOVVLcGhna2hsaDVlR0s0dlBlMWM5aHdlamp2bUlRcGgxaXJYcmxlQjMyODVwTlo1UkdSX1BxZw?oc=5" target="_blank">An update on the clinical trial research of immunotherapy for glioblastoma</a>  <font color="#6f6f6f">Frontiers</font>

Distinctive features of the tumor and immune microenvironment in glioblastoma | npj Precision Oncology
Natureworld

Distinctive features of the tumor and immune microenvironment in glioblastoma | npj Precision Oncology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA5VHRvcWg5OVo0cE5qNWZnem1EY1pISjBpbjBOS2ZCbEMySUx4NGRDQjUtSGNNMUJlczByRU5uaHM5MElDLXdDOVl6VXpwX085X3JMSXptS0NaQWZPX2hB?oc=5" target="_blank">Distinctive features of the tumor and immune microenvironment in glioblastoma | npj Precision Oncology</a>  <font color="#6f6f6f">Nature</font>

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
Frontiersworld

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOeUx5OXl4X0RhQTdGNGV1VFZGc2ZtMGxtaWZRdWdfbWtsN2kyZzBQTVRSXzlabEx5cHlSUUx1VmI3VGNON1g1U2N6QXVDVklwSVRTQzl2dTNsd2l6SDk4UVJjM1Qzdmd5Nk5Ec0FFTnhxTTRXaWZoQmhzdGZxN0ZpWllTRVZMWk83MnpCeVJSZTg?oc=5" target="_blank">Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions</a>  <font color="#6f6f6f">Frontiers</font>

Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
Naturegeneral

Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9NcVdEUmRodHgtbmJxMGxzY2hqYWxnd1N2MkxrLWtGcFdmc1pIaWpiYVNjUkY3T1VWbFNtM0cxSE8xM0ItN1ZNbllqZmMyOEdpTVF3M3BfLUxuMDlpU3BR?oc=5" target="_blank">Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity</a>  <font color="#6f6f6f">Nature</font>

Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy
Frontiersworld

Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQRVpuaVljb3doSjNzMTNybkNCdjNnZW9KU2laQ3Y0QjF0MlNVdGdPN0FidklKSFpPWU9RbnprLUpMNVM4OFZoRkxnSllhcmFlNkhzd1Z4d243VEdfd2xmRlU0RUY4MzVKTk1iVl9GOW5ocnhfTnphRWFZcDMyRDFDT21hSzA1TDFxalZjS050aHRRdw?oc=5" target="_blank">Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy</a>  <font color="#6f6f6f">Frontiers</font>

Lipid metabolism: the potential therapeutic targets in glioblastoma - Cell Death Discovery
Naturegeneral

Lipid metabolism: the potential therapeutic targets in glioblastoma - Cell Death Discovery

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9iZms0MDhjT3dSU19xVWlVeFJPbUgxdUtVeWVveWl1dG1hU0IzdlBaWHFTcmNfLXpOamtlUVhCb2M2UG5GYU5JZ18xQnhFMjltRlVCNlZ0NFV3NjBFc2JV?oc=5" target="_blank">Lipid metabolism: the potential therapeutic targets in glioblastoma - Cell Death Discovery</a>  <font color="#6f6f6f">Nature</font>

Current status, hotspots and frontiers of ion channel-related research in glioblastoma: a bibliometric analysis from 2005 to 2024
Frontiersgeneral

Current status, hotspots and frontiers of ion channel-related research in glioblastoma: a bibliometric analysis from 2005 to 2024

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNdEhweXJ3RHlYTnFWMDhRbHU5dldZRTNTOWdZYWthRzJrbGNVMG9aUlZxS0JqYjJiVXRGbnRGSmZUMlU0M1kxWTMwQXI0Tmk4QUtoQkljdk96NWxuMFYxc0NEaHJZR3FHMV9KeHlWZUdsX1JyNk1GVnI1d0wwR2lHd2tTMGxFcUlwQkhxSEZ3?oc=5" target="_blank">Current status, hotspots and frontiers of ion channel-related research in glioblastoma: a bibliometric analysis from 2005 to 2024</a>  <font color="#6f6f6f">Frontiers</font>

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment | Cell Death & Disease
Naturegeneral

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment | Cell Death & Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fYlY2amZ1Q0NBbnVvUUpVTHNRQUJWQXhqeFpoczR5aXFPeDB4dWczanF6NTRmUTEwWWo5b0N2UXlYVXJZN08wWmMyLXo4NHpuUGszbUhQdXE2Q2Q5VlF3?oc=5" target="_blank">Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment | Cell Death & Disease</a>  <font color="#6f6f6f">Nature</font>

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma
Frontiersworld

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOYVpOdldrWkVYQnFJckpEQm9sSGdoZDRRNy03anNleUNwTWpOZEUwcENIX2VSWFVzQ3Q1Q1NhU1JuUUVHYmdCZUhwVnVOajdrOTg4NG1LUzNCQ1poQnNPaXY0ek5IdmFJS0ZDaVpfRGxpempDeWdIeDhLaDBMcEJ1a3hIMzVwb0RQVExtODRQbE1jQQ?oc=5" target="_blank">Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma</a>  <font color="#6f6f6f">Frontiers</font>

Enhancing glioma immunotherapy by disrupting RBP-J-mediated NNMT signaling in tumor microenvironment
Natureworld

Enhancing glioma immunotherapy by disrupting RBP-J-mediated NNMT signaling in tumor microenvironment

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE54MVFyM3BtYXQ1YW9mUzVJWHpWczY3ejJCZDE3UXlVY0RiVjNIdGdWU0VCSXdsVG9CenpINFI0czV4Y0IxSGJQUFk1b1UxUXVKTFZQVUdCcVpzQkVZUEIw?oc=5" target="_blank">Enhancing glioma immunotherapy by disrupting RBP-J-mediated NNMT signaling in tumor microenvironment</a>  <font color="#6f6f6f">Nature</font>

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma
Naturetech

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBtR182LTRka2tTMm0zRG9Ba1QwQUl5SXVlMGlzWExVUWczbmp0ay1CWXVGZnBBX19mY2VaV3ZRUEI3Wl85T296TXhjUDllcGhOcjFHSTFETmRiaDB5RTNN?oc=5" target="_blank">Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma</a>  <font color="#6f6f6f">Nature</font>

Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
Frontiersworld

Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOaUZpMU5PM0ZKc2Rwd0FlSXBGVjZXQkFKazJ1YmFpNk5Nekw5cWJUdm12Vkpua01iN183WGtma0dFZThFMy1XOWlrMU9mZ2hwOWk2VlJja09mbERKUi1uMFQwazVlUEhDS2ZlRTI5NFJ2NjBFLUJibnhyb2NWLUJDU0J2X2dJLWJuTHBPRjMzZDdWX2t4?oc=5" target="_blank">Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies</a>  <font color="#6f6f6f">Frontiers</font>

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
Frontiersworld

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQc3RQZTREM1RHamlrTW83T3RvQWQ4R0Y0Z3FEeVNFVFBIc1BCYkR6STY1ZzN2V09GQm5QSTRFZ1BHeHZKMUNHMUVjNkhydHhkRTlKWTdFQVV0WG8wZ2MtYlgxSXFTNzFINEo1ZEpxS0VZa21IWXVZNld2bGhLR0lBSFV0Z1hKZVRXRzlYOHhNa0Q?oc=5" target="_blank">Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies</a>  <font color="#6f6f6f">Frontiers</font>

Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches
Wiley Online Libraryworld

Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE85Q1ZBSWJiT09BM29LTnRIZTc4Z1h2eDk4TXRjMWhOemx3b0h3Z0RnQXQ1eE9NZ1JCZkdRVFg5cWxRSkp3NVc5bFpzbnpuVExGTWF5d0dGZXBudWEtakx3R0h2bXNfLTV0X0E?oc=5" target="_blank">Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches</a>  <font color="#6f6f6f">Wiley Online Library</font>

Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate | Cell Death & Disease
Naturetech

Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate | Cell Death & Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE84TlpWb2RoWGJjalNLeTdRV1lHUzhhNXU4SmpadGNNbE5hckxTMVB6WnE2cjZhQ3BRekx2YXlrOUt0RERRaTRlSTQxQ0h4ajAzaUlFLUNFZzJoMXN1LWMw?oc=5" target="_blank">Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate | Cell Death & Disease</a>  <font color="#6f6f6f">Nature</font>

Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy
Frontierstech

Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPdXpQZDhZcUJxcXFvQWRSQjNndlJQWkw1dlBDN3J5SVRQQkdMOWc4Sm5IeHpxMnhkdFdFLUQyLWNZR0pyWGtqZTVFbEsyTEk1cVNBQ1FkZURPclB2MWU2bGtWVHhGUm8tc1ZwLWpjMjFCWHQ2ZU5Zd2p4UHlwTndsUFk0TldiVjg4cTFyM0d2SVY0TGEtX3RsMmhSeWdIMFpDdzZ0YU1FWHJZcTBQUFJV?oc=5" target="_blank">Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy</a>  <font color="#6f6f6f">Frontiers</font>

Macrophage-based therapeutic strategies in glioblastoma: advancements in drug delivery and immunotherapy
Frontiersworld

Macrophage-based therapeutic strategies in glioblastoma: advancements in drug delivery and immunotherapy

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPRm1QdTRtbWhsRXA4dHlrS28xdHkwUHM1T0s3YS1ER1V0RTdxU0p1c3VVRzRVZE5JX2dFUlR1dzNxTWx4NzB4OVFJXzkzb2h2dE03VmZhS0VHMi1XU3lUcUpiNmR5RE9yVUFTZWtHdGcwX3NtU1RQSjg3VmQyVVYxTnlPRnl5QzZPNkhUTzFR?oc=5" target="_blank">Macrophage-based therapeutic strategies in glioblastoma: advancements in drug delivery and immunotherapy</a>  <font color="#6f6f6f">Frontiers</font>

Semantic structure preservation for accurate multi-modal glioma diagnosis
Naturegeneral

Semantic structure preservation for accurate multi-modal glioma diagnosis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5xQjl6U0U0WExZMjVkM2t5X2RVS2hmREFTMUdySHplYVN2b3hWS2l4b25UU2tqSERJcXl3bFI4T2lqdmV5RDhDdVowdGNacjVMa0xGRWQ1aDlEUnM4YnNJ?oc=5" target="_blank">Semantic structure preservation for accurate multi-modal glioma diagnosis</a>  <font color="#6f6f6f">Nature</font>

Advances in immunotherapy for glioblastoma multiforme
Frontiersworld

Advances in immunotherapy for glioblastoma multiforme

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQY19vMUFFYWRIeHNhNXFrM1J3Tm1NREltYWhJblFkekdQb3lnczl2R1htekJXNnFGcy1sTUhrZGJmcDVzMDRMRTVJOVBYeHhOam5US0ZoZm5iX3VCRmJiUDc2cldHR21PZUFJZFd0VjRPbjNITEFVVTJHTHd6amN2dHNSVFFERm1rdnpGRTk0Uk0?oc=5" target="_blank">Advances in immunotherapy for glioblastoma multiforme</a>  <font color="#6f6f6f">Frontiers</font>

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Frontiersgeneral

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQYmc5OTZlLVFpSlBRRTVtTnhhX19aaHBqUmtiak1aTHVKRFJGNXV3dk9OUEZPUXBxaHZVTWxVMmZfLWhZMDhOT05OQk1neXV4WGZLZWs1eGYyMS1FUkF6WW5rX3hSYVpKbE9NWUhWX3ozSDE1MnlXcGlGaTNNaXhiSkp2NmV5WEt1MWpLMldybV9MUQ?oc=5" target="_blank">Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments</a>  <font color="#6f6f6f">Frontiers</font>

Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination
Frontiersworld

Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOVTVCb1MxcXl0Y25leDFrd2lfU3hWN0tneGlCQkdZWDVwRHhWZVBjWkEzLXFkT0phLU5QZHhySTcwQkYzaGZQeW9fZE9CME5Hb0JidkNoTFpVMmtmX21NWnhqa1A2ZnF0S1BINHhDTmxnRWcxbUxwMkl6UWNGQXVSY0otM2h3SF9qTVZBVA?oc=5" target="_blank">Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination</a>  <font color="#6f6f6f">Frontiers</font>

"Improving Glioblastoma Cl" — Live Google News Trends & Headlines